ICSMA-25-336-01

Vulnerability from csaf_cisa - Published: 2025-12-02 07:00 - Updated: 2025-12-02 07:00
Summary
Mirion Medical EC2 Software NMIS BioDose

Notes

Legal Notice and Terms of Use
This product is provided subject to this Notification (https://www.cisa.gov/notification) and this Privacy & Use policy (https://www.cisa.gov/privacy-policy).
Risk evaluation
Successful exploitation of these vulnerabilities could allow an attacker to modify program executables, gain access to sensitive information, gain unauthorized access to the application, and execute arbitrary code.
Critical infrastructure sectors
Healthcare and Public Health
Countries/areas deployed
Worldwide
Company headquarters location
United States
Recommended Practices
CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities, such as:
Recommended Practices
Minimize network exposure for all control system devices and/or systems, ensuring they are not accessible from the Internet.
Recommended Practices
Locate control system networks and remote devices behind firewalls and isolating them from business networks.
Recommended Practices
When remote access is required, use more secure methods, such as Virtual Private Networks (VPNs), recognizing VPNs may have vulnerabilities and should be updated to the most current version available. Also recognize VPN is only as secure as the connected devices.
Recommended Practices
CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.
Recommended Practices
CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov/ics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.
Recommended Practices
CISA encourages organizations to implement recommended cybersecurity strategies for proactive defense of ICS assets.
Recommended Practices
Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov/ics in the technical information paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.
Recommended Practices
Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.
Recommended Practices
CISA also recommends users take the following measures to protect themselves from social engineering attacks:
Recommended Practices
Do not click web links or open attachments in unsolicited email messages.
Recommended Practices
Refer to Recognizing and Avoiding Email Scams for more information on avoiding email scams.
Recommended Practices
Refer to Avoiding Social Engineering and Phishing Attacks for more information on social engineering attacks.
Recommended Practices
No known public exploitation specifically targeting these vulnerabilities has been reported to CISA at this time.
To clipboard 

{
  "document": {
    "acknowledgments": [
      {
        "names": [
          "Joe Dillon"
        ],
        "summary": "reporting these vulnerabilities to Mirion Medical"
      }
    ],
    "category": "csaf_security_advisory",
    "csaf_version": "2.0",
    "distribution": {
      "text": "Disclosure is not limited",
      "tlp": {
        "label": "WHITE",
        "url": "https://www.cisa.gov/news-events/news/traffic-light-protocol-tlp-definitions-and-usage"
      }
    },
    "lang": "en-US",
    "notes": [
      {
        "category": "legal_disclaimer",
        "text": "This product is provided subject to this Notification (https://www.cisa.gov/notification) and this Privacy \u0026 Use policy (https://www.cisa.gov/privacy-policy).",
        "title": "Legal Notice and Terms of Use"
      },
      {
        "category": "summary",
        "text": "Successful exploitation of these vulnerabilities could allow an attacker to modify program executables, gain access to sensitive information, gain unauthorized access to the application, and execute arbitrary code.",
        "title": "Risk evaluation"
      },
      {
        "category": "other",
        "text": "Healthcare and Public Health",
        "title": "Critical infrastructure sectors"
      },
      {
        "category": "other",
        "text": "Worldwide",
        "title": "Countries/areas deployed"
      },
      {
        "category": "other",
        "text": "United States",
        "title": "Company headquarters location"
      },
      {
        "category": "general",
        "text": "CISA recommends users take defensive measures to minimize the risk of exploitation of these vulnerabilities, such as:",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Minimize network exposure for all control system devices and/or systems, ensuring they are not accessible from the Internet.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Locate control system networks and remote devices behind firewalls and isolating them from business networks.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "When remote access is required, use more secure methods, such as Virtual Private Networks (VPNs), recognizing VPNs may have vulnerabilities and should be updated to the most current version available. Also recognize VPN is only as secure as the connected devices.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov/ics. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA encourages organizations to implement recommended cybersecurity strategies for proactive defense of ICS assets.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov/ics in the technical information paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA also recommends users take the following measures to protect themselves from social engineering attacks:",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Do not click web links or open attachments in unsolicited email messages.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Refer to Recognizing and Avoiding Email Scams for more information on avoiding email scams.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Refer to Avoiding Social Engineering and Phishing Attacks for more information on social engineering attacks.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "No known public exploitation specifically targeting these vulnerabilities has been reported to CISA at this time.",
        "title": "Recommended Practices"
      }
    ],
    "publisher": {
      "category": "coordinator",
      "contact_details": "central@cisa.dhs.gov",
      "name": "CISA",
      "namespace": "https://www.cisa.gov/"
    },
    "references": [
      {
        "category": "self",
        "summary": "ICS Advisory ICSMA-25-336-01 JSON",
        "url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2025/icsma-25-336-01.json"
      },
      {
        "category": "self",
        "summary": "ICSA Advisory ICSMA-25-336-01 - Web Version",
        "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ics/alerts/ICS-ALERT-10-301-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/resources-tools/resources/ics-recommended-practices"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/sites/default/files/publications/Cybersecurity_Best_Practices_for_Industrial_Control_Systems.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/topics/industrial-control-systems"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/sites/default/files/publications/emailscams0905.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ncas/tips/ST04-014"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/news-events/ics-alerts/ics-alert-10-301-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/news-events/news/targeted-cyber-intrusion-detection-and-mitigation-strategies-update-b"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/secure-our-world/teach-employees-avoid-phishing"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/news-events/news/avoiding-social-engineering-and-phishing-attacks"
      }
    ],
    "title": "Mirion Medical EC2 Software NMIS BioDose",
    "tracking": {
      "current_release_date": "2025-12-02T07:00:00.000000Z",
      "generator": {
        "date": "2025-12-01T23:13:37.921541Z",
        "engine": {
          "name": "CISA CSAF Generator",
          "version": "1.0.0"
        }
      },
      "id": "ICSMA-25-336-01",
      "initial_release_date": "2025-12-02T07:00:00.000000Z",
      "revision_history": [
        {
          "date": "2025-12-02T07:00:00.000000Z",
          "legacy_version": "Initial",
          "number": "1",
          "summary": "Initial Publication"
        }
      ],
      "status": "final",
      "version": "1"
    }
  },
  "product_tree": {
    "branches": [
      {
        "branches": [
          {
            "branches": [
              {
                "category": "product_version_range",
                "name": "\u003c23.0",
                "product": {
                  "name": "Mirion Medical EC2 Software NMIS BioDose: \u003c23.0",
                  "product_id": "CSAFPID-0001"
                }
              }
            ],
            "category": "product_name",
            "name": "EC2 Software NMIS BioDose"
          }
        ],
        "category": "vendor",
        "name": "Mirion Medical"
      }
    ]
  },
  "vulnerabilities": [
    {
      "cve": "CVE-2025-64642",
      "cwe": {
        "id": "CWE-732",
        "name": "Incorrect Permission Assignment for Critical Resource"
      },
      "notes": [
        {
          "category": "summary",
          "text": "NMIS/BioDose V22.02 and previous versions\u0027 installation directory paths by default have insecure file permissions, which in certain deployment scenarios can enable users on client workstations to modify the program executables and libraries.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "www.cve.org",
          "url": "https://www.cve.org/CVERecord?id=CVE-2025-64642"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.1#CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/4.0#CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:N/SI:N/SA:N"
        }
      ],
      "remediations": [
        {
          "category": "mitigation",
          "details": "Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support directly.",
          "product_ids": [
            "CSAFPID-0001"
          ],
          "url": "mailto:support@ec2software.com"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 8.0,
            "baseSeverity": "HIGH",
            "vectorString": "CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:H",
            "version": "3.1"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2025-64298",
      "cwe": {
        "id": "CWE-732",
        "name": "Incorrect Permission Assignment for Critical Resource"
      },
      "notes": [
        {
          "category": "summary",
          "text": "NMIS/BioDose V22.02 and previous version installations where the embedded Microsoft SQLServer Express is used are exposed in the Windows share accessed by clients in networked installs. By default, this directory has insecure directory paths that allow access to the SQL Server database and configuration files, which can contain sensitive data.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "www.cve.org",
          "url": "https://www.cve.org/CVERecord?id=CVE-2025-64298"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.1#CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/4.0#CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N"
        }
      ],
      "remediations": [
        {
          "category": "mitigation",
          "details": "Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support directly.",
          "product_ids": [
            "CSAFPID-0001"
          ],
          "url": "mailto:support@ec2software.com"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 8.4,
            "baseSeverity": "HIGH",
            "vectorString": "CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H",
            "version": "3.1"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2025-61940",
      "cwe": {
        "id": "CWE-603",
        "name": "Use of Client-Side Authentication"
      },
      "notes": [
        {
          "category": "summary",
          "text": "NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "www.cve.org",
          "url": "https://www.cve.org/CVERecord?id=CVE-2025-61940"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.1#CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/4.0#CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N"
        }
      ],
      "remediations": [
        {
          "category": "mitigation",
          "details": "Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support directly.",
          "product_ids": [
            "CSAFPID-0001"
          ],
          "url": "mailto:support@ec2software.com"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 8.3,
            "baseSeverity": "HIGH",
            "vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L",
            "version": "3.1"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2025-64778",
      "cwe": {
        "id": "CWE-798",
        "name": "Use of Hard-coded Credentials"
      },
      "notes": [
        {
          "category": "summary",
          "text": "NMIS/BioDose software V22.02 and previous versions contain executable binaries with plain text hard-coded passwords. These hard-coded passwords could allow unauthorized access to both the application and database.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "www.cve.org",
          "url": "https://www.cve.org/CVERecord?id=CVE-2025-64778"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.1#CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/4.0#CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N"
        }
      ],
      "remediations": [
        {
          "category": "mitigation",
          "details": "Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support directly.",
          "product_ids": [
            "CSAFPID-0001"
          ],
          "url": "mailto:support@ec2software.com"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 7.3,
            "baseSeverity": "HIGH",
            "vectorString": "CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L",
            "version": "3.1"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2025-62575",
      "cwe": {
        "id": "CWE-732",
        "name": "Incorrect Permission Assignment for Critical Resource"
      },
      "notes": [
        {
          "category": "summary",
          "text": "NMIS/BioDose V22.02 and previous versions rely on a Microsoft SQL Server database. The SQL user account \u0027nmdbuser\u0027 and other created accounts by default have the sysadmin role. This can lead to remote code execution through the use of certain built-in stored procedures.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001"
        ]
      },
      "references": [
        {
          "category": "external",
          "summary": "www.cve.org",
          "url": "https://www.cve.org/CVERecord?id=CVE-2025-62575"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/3.1#CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L"
        },
        {
          "category": "external",
          "summary": "www.first.org",
          "url": "https://www.first.org/cvss/calculator/4.0#CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N"
        }
      ],
      "remediations": [
        {
          "category": "mitigation",
          "details": "Mirion Medical recommends users update to V23.0 or later. Users with an active support contract should update to the latest version through the software or users can contact Mirion Medical support directly.",
          "product_ids": [
            "CSAFPID-0001"
          ],
          "url": "mailto:support@ec2software.com"
        }
      ],
      "scores": [
        {
          "cvss_v3": {
            "baseScore": 8.3,
            "baseSeverity": "HIGH",
            "vectorString": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L",
            "version": "3.1"
          },
          "products": [
            "CSAFPID-0001"
          ]
        }
      ]
    }
  ]
}


Log in or create an account to share your comment.




Tags
Taxonomy of the tags.




Sightings

Author Source Type Date

Nomenclature

  • Seen: The vulnerability was mentioned, discussed, or observed by the user.
  • Confirmed: The vulnerability has been validated from an analyst's perspective.
  • Published Proof of Concept: A public proof of concept is available for this vulnerability.
  • Exploited: The vulnerability was observed as exploited by the user who reported the sighting.
  • Patched: The vulnerability was observed as successfully patched by the user who reported the sighting.
  • Not exploited: The vulnerability was not observed as exploited by the user who reported the sighting.
  • Not confirmed: The user expressed doubt about the validity of the vulnerability.
  • Not patched: The vulnerability was not observed as successfully patched by the user who reported the sighting.



Detection rules are retrieved from Rulezet.